Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 224 citations, 2012 year and green oa status.